TRIO-TECH director exercises 70K options, sells 10K shares

TRIO-TECH INTERNATIONAL director Jason T. Adelman reported option exercises and share sales.

Rhea-AI Filing Summary

TRIO-TECH INTERNATIONAL director Jason T. Adelman reported option exercises and share sales. On June 23, 2026, he exercised derivative securities to acquire 70,000 shares of Common Stock at an exercise price of $3.11 per share, increasing his direct holdings.

Before that, he completed open-market sales of 5,000 shares at $15.84 per share on June 18, 2026 and 5,000 shares at $14.88 per share on June 19, 2026, for total sales of 10,000 shares. Following these transactions, he directly owns 210,094 shares of Common Stock, and the exercised derivative position is fully converted with no remaining derivative holdings reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider ADELMAN JASON T

Role Director

Sold 10,000 shs ($154K)

Approx. gross sale proceeds $154K

Approx. exercise cost $218K

Type	Security	Shares	Price	Value
Exercise	Common Stock (Right to Buy)	70,000	$0.00	$0.00
Exercise	Common Stock	70,000	$3.11	$218K
Sale	Common Stock	5,000	$14.88	$74K
Sale	Common Stock	5,000	$15.84	$79K

Holdings After Transaction: Common Stock (Right to Buy) — 0 contracts (Direct); Common Stock — 210,094 shares (Direct)

Key Figures

Options exercised: 70,000 shares Exercise price: $3.11 per share Sale on June 18, 2026: 5,000 shares at $15.84 +5 more

8 metrics

Options exercised 70,000 shares Common Stock acquired via derivative exercise on June 23, 2026

Exercise price $3.11 per share Price for exercising “Common Stock (Right to Buy)” derivative

Sale on June 18, 2026 5,000 shares at $15.84 Open-market sale of Common Stock

Sale on June 19, 2026 5,000 shares at $14.88 Open-market sale of Common Stock

Total shares sold 10,000 shares Aggregate open-market sales on June 18–19, 2026

Shares owned after 210,094 shares Direct Common Stock holdings following transactions

Derivative shares remaining 0 shares Common Stock (Right to Buy) position after exercise

Option expiration date March 25, 2030 Original expiration for exercised derivative grant

Key Terms

Form 4, open-market sale, derivative security, Common Stock (Right to Buy), +1 more

5 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Common Stock (Right to Buy) financial

"security_title": "Common Stock (Right to Buy)""

transaction_code "M" regulatory

"transaction_code": "M""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did TRT director Jason T. Adelman report?

Jason T. Adelman reported exercising options for 70,000 TRT common shares and selling 10,000 shares. The exercise occurred on June 23, 2026, while the sales took place on June 18 and 19, 2026, in open-market transactions at prices above $14 per share.

How many TRIO-TECH INTERNATIONAL (TRT) shares does Jason T. Adelman hold after these transactions?

After the reported transactions, Jason T. Adelman directly holds 210,094 TRT common shares. This figure reflects both the 70,000-share option exercise on June 23, 2026, and the two open-market sales totaling 10,000 shares executed on June 18 and 19, 2026.

At what prices did Jason T. Adelman sell TRT shares in the open market?

He sold 5,000 TRT common shares at $15.84 per share on June 18, 2026, and another 5,000 shares at $14.88 per share on June 19, 2026. These transactions are classified as open-market or private sales in the Form 4 filing.

What was the exercise price for Jason T. Adelman’s TRT stock options?

The derivative securities labeled “Common Stock (Right to Buy)” were exercised at $3.11 per share. Exercising these rights on June 23, 2026, converted them into 70,000 shares of TRT common stock and reduced the remaining derivative position under that grant to zero.

Did Jason T. Adelman retain any TRT derivative securities after the reported option exercise?

No, the filing shows that after exercising 70,000 “Common Stock (Right to Buy)” derivatives, the total derivative shares following the transaction are zero. This indicates the specific derivative position reported was fully exercised into common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2026 - 02:34 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ADELMAN JASON T

(Last) (First) (Middle)

C/O TRIO-TECH INTERNATIONAL

16139 WYANDOTTE ST

(Street)

VAN NUYS CALIFORNIA 91406

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TRIO-TECH INTERNATIONAL [ TRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2026		S		5,000	D	$15.84	145,094	D
Common Stock	06/19/2026		S		5,000	D	$14.88	140,094	D
Common Stock	06/23/2026		M		70,000	A	$3.11	210,094	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$3.11	06/23/2026		M			70,000	03/26/2025	03/25/2030	Common Stock	70,000	$0	0	D

Explanation of Responses:

	/s/ Jason Adelman	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)